EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C7H11NO4 |
| Net Charge | 0 |
| Average Mass | 173.168 |
| Monoisotopic Mass | 173.06881 |
| SMILES | CC(=O)N1C[C@H](O)C[C@H]1C(=O)O |
| InChI | InChI=1S/C7H11NO4/c1-4(9)8-3-5(10)2-6(8)7(11)12/h5-6,10H,2-3H2,1H3,(H,11,12)/t5-,6+/m1/s1 |
| InChIKey | BAPRUDZDYCKSOQ-RITPCOANSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Applications: | anti-inflammatory drug A substance that reduces or suppresses inflammation. dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| oxaceprol (CHEBI:233149) has role anti-inflammatory drug (CHEBI:35472) |
| oxaceprol (CHEBI:233149) has role dermatologic drug (CHEBI:50177) |
| oxaceprol (CHEBI:233149) is a L-proline derivative (CHEBI:84186) |
| oxaceprol (CHEBI:233149) is a acetamides (CHEBI:22160) |
| oxaceprol (CHEBI:233149) is a monohydroxypyrrolidine (CHEBI:46777) |
| oxaceprol (CHEBI:233149) is a pyrrolidinemonocarboxylic acid (CHEBI:46701) |
| IUPAC Name |
|---|
| (4R)-1-acetyl-4-hydroxy-L-proline |
| INNs | Source |
|---|---|
| oxaceprol | WHO MedNet |
| oxaceprolum | WHO MedNet |
| oxaceprol | WHO MedNet |
| oxacéprol | WHO MedNet |
| Synonyms | Source |
|---|---|
| (2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid | IUPAC |
| (R)-N-acetyl-4-hydroxy-L-proline | ChEBI |
| N-acetyl-trans-4-hydroxy-L-proline | ChEBI |
| trans-N-acetyl-4-hydroxy-L-proline | ChEBI |
| Brand Name | Source |
|---|---|
| Jonctum | KEGG DRUG |
| Citations |
|---|